Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VII

7GC & Co. Holdings Inc. (VII) Stock Price, News & Analysis

About 7GC & Co. Holdings Inc. Stock (NASDAQ:VII)

Advanced Chart

Key Stats

Today's Range
$0.17
$0.26
50-Day Range
$10.96
$10.96
52-Week Range
$9.00
$16.57
Volume
797,148 shs
Average Volume
39,241 shs
Market Capitalization
$1.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

7GC & Co. Holdings Inc. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business opportunities in the field of technology. 7GC & Co. Holdings Inc. was incorporated in 2020 and is based in San Francisco, California.

Receive VII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 7GC & Co. Holdings Inc. and its competitors with MarketBeat's FREE daily newsletter.

VII Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
G-7 Holdings Reports Sales Growth Amid Profit Challenges
See More Headlines

VII Stock Analysis - Frequently Asked Questions

7GC & Co. Holdings Inc. (NASDAQ:VII) released its earnings results on Monday, May, 14th. The company reported ($0.08) EPS for the quarter. The company had revenue of $7.32 million for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that 7GC & Co. Holdings Inc. investors own include Canopy Growth (CGC), Allena Pharmaceuticals (ALNA), Biocept (BIOC), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF) and AcelRx Pharmaceuticals (ACRX).

Company Calendar

Last Earnings
5/14/2018
Today
5/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:VII
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$9.44 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.03 per share
Price / Cash Flow
6.68
Book Value
($2.34) per share
Price / Book
-0.09

Miscellaneous

Free Float
4,259,000
Market Cap
$1.87 million
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:VII) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners